2,200 per cent returns and 52-week high alert: Vijay Kedia gains Rs 23,80,42,000 in this multibagger pharma stock in just one day; reports strong growth in profits!
Shares of the company gained more than 70 per cent in the last six months.
Shares of Neuland Laboratories Limited gained more than 18 per cent on Friday. The stock has witnessed heavy buying activity from investors from the last few days. In the last six months, the stock has gained more than 70 per cent. The stock also made a new 52-week high.
The company posted brilliant Quarterly Results. The revenue of the company for Q1FY25 stood at Rs 439.60 crore which grew by 21.1 per cent YoY. The operating profit of the company stood at Rs 128.17 crore. The PAT of the company stood at Rs 97.87 crore, representing an impressive growth of 58.17 per cent YoY.
Vijay Kedia, an ace investor, made a killing on Friday. His 1,40,000 shares in Neuland Laboratories, each of which increased by Rs 1,700.30, netted him a profit of Rs 23.80 crore in a single day.
DSIJ’s 'multibagger Pick’ service recommends well researched multibagger stocks with High Returns potential. If this interests you, do download the service details here.
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The company houses 15 development facilities inside its only R&D center in Hyderabad. It has 973+ DMFs filed, 100+ API processes developed, 67 Active US DMFs & 204+ patents filed to date. The shares of Neuland Laboratories Limited have also delivered multibagger returns of over 2,200 per cent in the last five years. Ace investor Vijay Kedia (Kedia Securities Private Limited) owns a 1.09 per cent stake in the company.
The stock has shown tremendous growth, and investors should keep a close eye on this stock.
Disclaimer: The article is for informational purposes only and not investment advice.